Testing effectiveness (Phase 2)Active Not RecruitingNCT04266249
What this trial is testing
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+6 more
ECOG-ACRIN Cancer Research Group 2,175